NK

Neeraj Kumar Upadhyay

Active Director Managing Director DIN 10625191
DIN 10625191 First appointment May 2024 Primary industry Paper
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Neeraj Kumar Upadhyay

Data last updated:

Neeraj Kumar Upadhyay is a Managing Director at Blacktree Drugs & Pharma Private Limited (since 2024). The company operates in Paper.

DIN 10625191
Primary Designation Managing Director
Industry Paper
First Appointment 13 May 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Managing Director13 May 20242024Active

Board colleagues of Neeraj Kumar Upadhyay

NameDINCompanyDesignation
Sanyogita Upadhyay10625190Blacktree Drugs & Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Blacktree Drugs & Pharma Private Limited
Premium access

Shareholding and investment profile for Neeraj Kumar Upadhyay

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Neeraj Kumar Upadhyay

Neeraj Kumar Upadhyay currently holds 1 directorship: Blacktree Drugs & Pharma Private Limited (Managing Director, since 13 May 2024).

Neeraj Kumar Upadhyay was first appointed on 13 May 2024 as Managing Director at Blacktree Drugs & Pharma Private Limited.

The current boards of Neeraj Kumar Upadhyay's companies include Sanyogita Upadhyay (Blacktree Drugs & Pharma Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available